Osteogenix Pharma Private Limited

Osteogenix Pharma Private Limited - business services in Delhi, India. Directors, charges & compliance details.
CIN U47721DL2023PTC419648 Incorporated 06 September 2023 ROC Delhi HQ Delhi, India
Active Private Limited Company
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
Registrar
Delhi
ROC office

About Osteogenix Pharma Private Limited

Data last updated:

Osteogenix Pharma Private Limited is a private limited company based in Delhi, India. It was incorporated on 06 September 2023.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U47721DL2023PTC419648.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Kumar (Managing Director) and Mahima.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 4 Jain Colony, Nanesh Enclave, Delhi, India – 110039.

Company details

CIN U47721DL2023PTC419648
Registration Number 419648
Incorporation Date 06 September 2023
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Osteogenix Pharma Private Limited's registered office is in Delhi, Delhi.

  • Registered Address
    B – 4 Jain Colony, Nanesh Enclave, Delhi, India – 110039
Comprehensive company report
Osteogenix Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Osteogenix Pharma Private Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Osteogenix Pharma Private Limited, buy the company report.

Board of directors of Osteogenix Pharma Private Limited

Osteogenix Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Prashant KumarManaging Director06 Sep 20233 Years 2 MonthsCurrent
MahimaDirector06 Sep 20233 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Osteogenix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Osteogenix Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Osteogenix Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Mahima was appointed as Director on 06 Sep 2023.

AGM
Osteogenix Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Osteogenix Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Mahima was appointed as Director.
Appointed
Prashant Kumar was appointed as Managing Director.
Incorporation
06 Sep 2023
Osteogenix Pharma Private Limited was registered on 06 Sep 2023 with Roc Delhi Ii & aged 3 years 2 months as per MCA records.

Frequently asked questions

Osteogenix Pharma is an active private limited company based in Delhi, India. It was incorporated on 06 September 2023 (3+ years old) and is registered under CIN U47721DL2023PTC419648.

Osteogenix Pharma has 2 current directors:

The latest financial statements of Osteogenix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Osteogenix Pharma is U47721DL2023PTC419648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Osteogenix Pharma was incorporated on 06 September 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.

Mahima was appointed as Director on 06 Sep 2023. Prashant Kumar was appointed as Managing Director on 06 Sep 2023.

The registered office of Osteogenix Pharma is at B – 4 Jain Colony, Nanesh Enclave, Delhi, India – 110039.

Osteogenix Pharma can be reached at its registered office: B – 4 Jain Colony, Nanesh Enclave, Delhi, India – 110039.

Osteogenix Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.